{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:46:12Z","timestamp":1773755172855,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,3,18]],"date-time":"2002-03-18T00:00:00Z","timestamp":1016409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2002,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatic venoocclusive disease (VOD) is the most common complication of cytoreductive therapy used for stem cell transplantation, but it is rarely encountered during induction treatment of acute leukemia. We describe a patient in whom severe clinical VOD developed shortly after induction treatment for acute monoblastic leukemia. Administration of intravenous defibrotide for 19 days induced complete resolution of the VOD. Further consolidation treatment was resumed including high\u2010dose cytosine arabinoside without further complications. Am. J. Hematol. 69:281\u2013284, 2002. \u00a9 2002 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.10072","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T19:21:03Z","timestamp":1030303263000},"page":"281-284","source":"Crossref","is-referenced-by-count":16,"title":["Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide"],"prefix":"10.1002","volume":"69","author":[{"given":"Osnat","family":"Bairey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilia","family":"Kirgner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Yakobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraf","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziv","family":"Ben\u2010Ari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mati","family":"Shaklai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,3,18]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90266-4"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-4-199302150-00003"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-5-578"},{"key":"e_1_2_1_6_2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","article-title":"Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation","volume":"9","author":"Bearman SI","year":"1993","journal-title":"J Clin Oncol"},{"key":"e_1_2_1_7_2","first-page":"551","article-title":"Chemotherapeutic agents and hepatotoxicity","volume":"19","author":"Perry MC","year":"1992","journal-title":"Semin Oncol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841201)54:11<2360::AID-CNCR2820541109>3.0.CO;2-D"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197710)40:4<1390::AID-CNCR2820400404>3.0.CO;2-T"},{"key":"e_1_2_1_10_2","first-page":"132","article-title":"Jaundice and hyperbilirubinemia following fludarabine, cytarabine, and idarubicin","volume":"31","author":"Trinkle R","year":"1996","journal-title":"Hosp Pharm"},{"key":"e_1_2_1_11_2","first-page":"217","article-title":"Jaundice and hepatorenal syndrome associated with cytosine arabinoside","volume":"82","author":"Kirtley DW","year":"1990","journal-title":"J Natl Med Assoc"},{"key":"e_1_2_1_12_2","first-page":"3599","article-title":"Incidence and outcome of hepatic veno\u2010occlusive disease after blood or bone marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras E","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_13_2","first-page":"439","article-title":"A comparison of clinical criteria for the diagnosis of veno\u2010occlusive disease of the liver after bone marrow transplantation","volume":"10","author":"Blostein MD","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V32.4.507.507"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90368-X"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2435::AID-CNCR21>3.0.CO;2-R"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(95)00082-8"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190515"},{"key":"e_1_2_1_19_2","first-page":"147","article-title":"Hepatic veno\u2010occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation","volume":"8","author":"Morio S","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199345020-00007"},{"key":"e_1_2_1_21_2","first-page":"71","article-title":"An integrated view of the activities of defibrotide","volume":"22","author":"Pescador R","year":"1996","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_1_22_2","first-page":"737","article-title":"Treatment of severe veno\u2010occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high\u2010risk population","volume":"92","author":"Richardson PG","year":"1998","journal-title":"Blood"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701650"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02475.x"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.10072","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.10072","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T06:23:59Z","timestamp":1700288639000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.10072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,18]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["10.1002\/ajh.10072"],"URL":"https:\/\/doi.org\/10.1002\/ajh.10072","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,18]]}}}